3 tailwind stocks for powerful returns

If I didn't already own these three top notch companies, I'd be placing an order today!

| More on:
a woman

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Tailwind investing… What is it and how can you make it work for you? Well the first question is easy, tailwind investing is investing in businesses that are likely to face a long-term improvement in business conditions. I'll get to the second question, but first, I want to introduce Warren Buffett's Noah principle (from his 1980 Letter to Shareholders):

Noah Principle: Predicting rain doesn't count, building arks does.

It was all very well to accurately predict the explosion in internet and mobile data use, but that alone was not enough. Those investors who bought shares in Telstra Corporation Ltd (ASX: TLS) in 2011, around the time it was clear Telstra would be a beneficiary of these trends, are sitting on gains of over 100% in less than three years including dividends – and that's a blue-chip stock! Smaller companies can generate much higher returns as they grow…

So with that in mind, here are three small companies that tailwind investors are watching:

1) SDI Limited (ASX: SDI) is a company that makes and distributes amalgam and composite restorative materials for dentists and is already up over 20% since certain value investors identified the opportunity recently. Although I did buy shares myself, I'm not as enthusiastic as some others because the company's products – while competitively priced – are no longer favoured by dentists in Australia.

Having said that the company recently announced its second-half results would be much improved on the prior corresponding period and the price remains reasonably attractive at just under 60c (though my purchase price is lower). Directors have been buying significant chunks of shares at less than 10% below current prices, indicating that shares are unlikely to be particularly overvalued.

Potential tailwinds: The company exports 90% of products. Worldwide, I posit that humans are living longer and becoming more aware of dental health, especially in places like Brazil and China where poverty is, gradually, being alleviated. SDI should benefit from this trend. Also, as the mining capex boom subsides, the Australian dollar should weaken, boosting SDI's profits in AUD terms.

2) CPT Global Limited (ASX: CGO) is a small IT company that specialises in performance tuning. That means it improves on the systems set up by other IT crews with goals such as improving speeds, reducing required computing resources or adding a greater number of users more easily. While I'm generally not a fan of the lumpy and often unpredictable nature of IT consulting revenues, I'm very attracted to the current price of CPT Global. The stock is quite illiquid, so savvy buyers will exhibit patience – there have been sellers at 70c for quite some time. Though the upcoming dividend is not known, it's quite possible the company will pay a generous dividend yield of over 8% (annualised).

Potential Tailwind: IT systems continue to become more complex as software and hardware improves. As a result, so does the potential benefit of getting the "second opinion" that CPT Global can provide.

3) Somnomed Limited (ASX: SOM) is a company that makes and sells mouthguard-like devices for continuous open airway therapy for sleep apnoea. While Somnomed faces formidable competition from ResMed Inc. (CHESS) (ASX: RMD) and Fisher & Paykel Healthcare Corp Ltd (ASX: FPH), there is a point of differentiation because Somnomed's product is far more portable (and quieter, as it is not a machine).

Potential Tailwinds: Not only are people becoming more mobile (making portability important), but sleep apnoea is more common in older, overweight people. The ageing population will therefore increase the number of sleep apnoea patients as will the ongoing obesity epidemic.

Motley Fool contributor Claude Walker (@claudedwalker) owns shares in Somnomed, SDI Limited, and CPT Global. Disclosure is important, so good on you for reading this far.

More on ⏸️ Investing

A white and black robot in the form of a human being stands in front of a green graphic holding a laptop and discussing robotics and automation ASX shares
Technology Shares

Joining the revolution: How I'd invest in ASX AI shares right now

Advances in artificial intelligence (AI) could usher in a new industrial revolution. Here’s how you can invest in it.

Read more »

Close up of baby looking puzzled
Retail Shares

What has happened to the Baby Bunting (ASX:BBN) share price this year?

It's been a volatile year so far for the Aussie nursery retailer. We take a closer look

Read more »

woman holds sign saying 'we need change' at climate change protest
ETFs

3 ASX ETFs that invest in companies fighting climate change

If you want to shift some of your investments into more ethical companies, exchange-traded funds can offer a good option

Read more »

a jewellery store attendant stands at a cabinet displaying opulent necklaces and earrings featuring diamonds and precious stones.
⏸️ Investing

The Michael Hill (ASX: MHJ) share price poised for growth

Investors will be keeping an eye on the Michael Hill International Limited (ASX: MHJ) share price today. The keen interest…

Read more »

ASX shares buy unstoppable asx share price represented by man in superman cape pointing skyward
⏸️ Investing

The Atomos (ASX:AMS) share price is up 15% in a week

The Atomos (ASX: AMS) share price has surged 15% this week. Let's look at what's ahead as the company build…

Read more »

Two people in suits arm wrestle on a black and white chess board.
Retail Shares

How does the Temple & Webster (ASX:TPW) share price stack up against Nick Scali (ASX:NCK)?

How does the Temple & Webster (ASX: TPW) share price stack up against rival furniture retailer Nick Scali Limited (ASX:…

Read more »

A medical researcher works on a bichip, indicating share price movement in ASX tech companies
Healthcare Shares

The Aroa (ASX:ARX) share price has surged 60% since its IPO

The Aroa (ASX:ARX) share price has surged 60% since the Polynovo (ASX: PNV) competitor listed on the ASX in July.…

Read more »

asx investor daydreaming about US shares
⏸️ How to Invest

How to buy US shares from Australia right now

If you have been wondering how to buy US shares from Australia to gain exposure from the highly topical market,…

Read more »